Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

6 pharma firms rank among Glassdoor’s 2021 Best Places to Work

By Brian Buntz | June 22, 2021

GlassdoorGlassdoor has released its latest list of the top 100 best places to work in 2021, and six pharmaceutical companies made the cut. One thread running across the entries in the entire list is the employers’ ability to empower and inspire workers in a time of continued challenges.

In addition to the pharma companies, the Glassdoor ranking featured a handful of medical device companies as well, including Stryker (14/100) and Intuitive Surgical (41/100).

Johnson & Johnson: 24 out of 100

Johnson & JohnsonJ&J (NYSE:JNJ) has come up in the ranks since we published our list of the top pharma companies to work for in May. J&J employees on Glassdoor praised the opportunities with various departments, the overall work environment and the work-life balance their roles afforded.

Johnson & Johnson was also the top-ranked pharmaceutical company in Gartner’s most recent list of top 25 supply chain companies, coming in at slot three. “J&J remains unparalleled in the life science industry, possessing enduring leadership, operational strengths and expertise in supporting innovation,” Gartner wrote in the report.

The company’s CEO, Alex Gorsky, was also featured among the Glassdoor 2021 Top 100 CEOs, where he was listed at slot 29.

Pfizer: 39 out of 100

PfizerPfizer (NYSE:PFE) employees appreciated the firm’s culture, benefits and support for R&D. Pfizer also came in at slot 21 on Forbes’ list of America’s Best Employers for Diversity. On Glassdoor, 85% of Pfizer employees said they would recommend the company to a friend.

Pfizer also came in at slot 21 in Gartner’s ranking of top 25 supply chain companies.

Merck: 63 out of 100

Merck logoMerck (NYSE:MRK) had solid scores for its senior leadership and benefits. Employees also said they were pleased with the company’s response to the COVID-19 pandemic when it provided pay during a shutdown. On Glassdoor, a total of 86% of employees would recommend Merck to a friend.

Merck’s CEO Kenneth Frazier also had an especially high approval rating of 96% on Glassdoor. Frazier, however, is leaving his leadership role on June 30.

Bristol Myers Squibb: 78 out of 100

Bristol Myers SquibbBristol Myers Squibb (NYSE:BMY) employees were pleased with the company’s support during the height of the COVID-19 pandemic. The company has also gone to significant lengths to shore up its pharma supply chain during the pandemic. Gartner also ranked Bristol Myers Squibb in its list of top 25 supply chain companies.

Bristol Myers Squibb has an average score of 4.1 on Glassdoor.

Eli Lilly: 87 out of 100

Eli LillyLilly (NYSE:LLY) employees praised the firm’s benefits, culture and mission. A total of 83% of workers there would recommend the company to others.

A total of 83% Lilly employees on Glassdoor would recommend the company to a friend.

Lilly wasn’t included in our May ranking of top 10 pharma employers.

Novartis: 92 out of 100

Novartis

Employees at Novartis (NYSE:NVS) appreciated the company’s wages and diversity program. A significant number of Novartis employees using Glassdoor also praised its work environment and benefits.

Novartis CEO, Vas Narasimhan, was also featured as one of the Glassdoor 2021 Top 100 CEOs, coming in at slot 23.


Filed Under: Drug Discovery and Development
Tagged With: Bristol-Myers Squibb, Eli Lilly, Glassdoor, Johnson & Johnson, Merck, Novartis, Pfizer
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE